End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
Financials (USD)
Sales 2021 | 3.6 | Sales 2022 | 2.51 | Capitalization | 14.29M |
---|---|---|---|---|---|
Net income 2021 | -237M | Net income 2022 | -70M | EV / Sales 2021 | 53,517,059 x |
Net cash position 2021 | 45.01M | Net cash position 2022 | 10.16M | EV / Sales 2022 | 1,644,636 x |
P/E ratio 2021 |
-0.92
x | P/E ratio 2022 |
-0.15
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.65% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Durrant
CEO | Chief Executive Officer | 63 | 16-01-06 |
Omar Ahmed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dale B. Chappell
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Durrant
CEO | Chief Executive Officer | 63 | 16-01-06 |
Dale B. Chappell
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-07-05 |
Ronald Barliant
BRD | Director/Board Member | 78 | 16-01-06 |
1st Jan change | Capi. | |
---|---|---|
-4.71% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |